Immune Abnormalities Induced by Human Endogenous Retroviral Peptides: With Reference to the Pathogenesis of Systemic Lupus Erythematosus
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
P15E is a specific sequence among the envelope gene (env)-encoded transmembrane proteins of exogenous and endogenous retroviruses. A synthetic peptide (CKS- 17) that shows homology to this p15E region in several species of retrovirus is known to induce immune abnormalities. In this study, we examined the effect of a synthetic peptide derived from a region of human endogenous retrovirus (HERV) clone 4-1 (lambda4 - 1) similar to sequences of CKS-17 on the induction of systemic lupus erythematosus (SLE)-related immune abnormalities. Our results indicated that this peptide could induce T-cell activation and anergy in normal peripheral blood mononuclear cells, and the peptide could also promote the production of interleukins IL-6 and IL-16. These phenomena are representative immune abnormalities observed in SLE patients. Thus, our findings support the possibility that HERV acts as a pathogen in human SLE.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, immunosuppressive potential has been demonstrated for the env of HERV-E 52, HERV-H 53, as well as syncytins 54.”
From Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis (2013) · cites this paper as [52]
Citations
Cites
MHC ligands and peptide motifs: first listing
Rammensee, H.-G., Friede, T., & Stevanović, S. (1995) · Immunogenetics · doi:10.1007/bf00172063 · Cited by 1,638 · cited 1×
“Supporting this, endogenous antigens such as HERV are known to be usually recognized by CD8 + T cells (11, 31).”
BackgroundCianciolo, G. J., Copeland, T. D., Oroszlan, S., & Snyderman, R. (1985) · Science · doi:10.1126/science.2996136 · Cited by 451 · cited 3×
“This clone 4-1 p15E shares significant amino acid (aa) sequence homology with retroviral p15E from other species (3).”
BackgroundMHC Ligands and Peptide Motifs
Rammensee, H.-G., Bachmann, J., & Stevanović, S. (1997) · Molecular Biology Intelligence Unit · doi:10.1007/978-3-662-22162-4 · Cited by 331
Interleukin 16 and its function as a CD4 ligand
Center, D. M., Kornfeld, H., & Cruikshank, W. W. (1996) · Immunology Today · doi:10.1016/0167-5699(96)10052-i · Cited by 254 · cited 3×
“This cytokine is a competence growth factor for CD4 + T cells, and it is capable of inducing a G0 to G1 cell cycle transition, but incapable of inducing cell division (15,18).”
BackgroundNucleotide sequence of a full-length human endogenous retroviral segment
Repaske, R., Steele, P. E., O'Neill, R. R., Rabson, A. B., & Martin, M. A. (1985) · Journal of Virology · doi:10.1128/jvi.54.3.764-772.1985 · Cited by 163
Ruegg, C. L., Monell, C. R., & Strand, M. (1989) · Journal of Virology · doi:10.1128/jvi.63.8.3257-3260.1989 · Cited by 122 · cited 1×
“Computer-assisted sequence analysis has been utilized by other investigators to identify a highly conserved region of the retroviral TM proteins p15E of several species (5,6), and the consensus sequence is represented by the synthetic peptide CKS-17 (3).”
The Potential Roles of Endogenous Retroviruses in Autoimmunity
Nakagawa, K., & Harrison, L. C. (1996) · Immunological Reviews · doi:10.1111/j.1600-065x.1996.tb00917.x · Cited by 121
Harris, D. T., Cianciolo, G. J., D, R. S. M., Argov, S., & Koren, H. S. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.3.889 · Cited by 104 · cited 1×
“A peptide (CKS-17) that was synthesized to correspond to this homologous region is reported to induce immune abnormalities such as inhibition of T-cell proliferation and natural killer cell activity (3, 4, 6).”
BackgroundCirculating interleukin-16 in systemic lupus erythematosus
Lee, S. (1998) · British journal of rheumatology · doi:10.1093/rheumatology/37.12.1334 · Cited by 84 · cited 3×
“Our previous cross-sectional study indicated that serum levels of IL-16 are much higher in SLE patients than in healthy volunteers, and an increase of IL-16 occurs in proportion to disease activity as assessed by the SLE Disease Activity Index (SLEDAI) score (16, 19).”
BackgroundHISHIKAWA, T., OGASAWARA, H., KANEKO, H., SHIRASAWA, T., MATSUURA, Y., SEKIGAWA, I., TAKASAKI, Y., HASHIMOTO, H., HIROSE, S., HANDA, S., et al. (1997) · Viral Immunology · doi:10.1089/vim.1997.10.137 · Cited by 71
Self-citationHaraguchi, S., Good, R. A., Cianciolo, G. J., Engelman, R. W., & Day, N. K. B. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.6.654 · Cited by 65
Okada, M., Ogasawara, H., Kaneko, H., Hishikawa, T., Sekigawa, I., Hashimoto, H., Maruyama, N., Kaneko, Y., & Yamamoto, N. (2002) · PubMed · Cited by 64
Self-citationOgasawara, H., Naito, T., Kaneko, H., Hishikawa, T., Sekigawa, I., Hashimoto, H., Kaneko, Y., Yamamoto, N., Maruyama, N., & Yamamoto, N. (2001) · PubMed · Cited by 61
Self-citationRetroviruses and autoimmune rheumatic diseases
Kalden, J. R., & Gay, S. (1994) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06597.x · Cited by 55
Lard, L. R., Roep, B. O., Verburgh, C. A., Zwinderman, A. H., & Huizinga, T. W. J. (2002) · Lupus · doi:10.1191/0961203302lu176sr · Cited by 53 · cited 3×
“IL-16 seems to show the most intimate relationship with disease activity among several serum cytokines detected in SLE (16,17).”
BackgroundRelationship between CD4+/CD8+ T Cell Ratio and T Cell Activation in Systemic Lupus Erythematosus
N Maeda, I. S. (1999) · Scandinavian Journal of Rheumatology · doi:10.1080/03009749950154248 · Cited by 53 · cited 1×
“Several reports including ours have indicated that HLA-DR expression on CD8 + T cells is increased more strongly than that of CD4 + T cells in SLE patients, and a decrease of CD4 + T-cell numbers in patients with SLE shows a significant inverse correlation with the increase of HLA-DR expression by CD8 + T cells and th…”
Retroviruses and Autoimmunity.
Sekigawa, I., Ogasawara, H., Kaneko, H., Hishikawa, T., & Hashimoto, H. (2001) · Internal Medicine · doi:10.2169/internalmedicine.40.80 · Cited by 47 · cited 1×
“Supporting this, endogenous antigens such as HERV are known to be usually recognized by CD8 + T cells (11, 31).”
BackgroundSelf-citationPerspectives on the Role of Endogenous Human Retroviruses in Autoimmune Diseases
Portis, J. L. (2002) · Virology · doi:10.1006/viro.2002.1388 · Cited by 46 · cited 1×
“However, there have also been negative views regarding their role in autoimmune diseases including SLE (26).”
BackgroundNef protein of HIV-1 has B-cell stimulatory activity
Chirmule, N. B., Oyaizu, N., Saxinger, C. W., & Pahwa, S. G. (1994) · AIDS · doi:10.1097/00002030-199406000-00002 · Cited by 44 · cited 2×
“5), and this may be related to polyclonal B cell activation (PBA) in SLE patients, as reported previously (1,20).”
BackgroundMethodRetroviruses and Systemic Lupus Erythematosus
i, M. H., Hagenhofer, M., & Kalden, J. R. (1996) · Immunological Reviews · doi:10.1111/j.1600-065x.1996.tb00914.x · Cited by 42
HLA-DP+ T cells and deficient interleukin-2 production in patients with systemic lupus erythematosus
Hishikawa, T., Tokano, Y., Sekigawa, I., Ando, S., Takasaki, Y., Hashimoto, H., Hirose, S., Okumura, K., Abe, M., & Shirai, T. (1990) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(90)90104-x · Cited by 41 · cited 1×
“Although HLA-DR is generally expressed by B cells and macrophages, this antigen is also known to be expressed on an extremely small population of T cells and a large population of activated T cells (mainly in the G1A–B phases, but not G0 phase, of the cell cycle) (22).”
BackgroundSelf-citationSequence Analysis of Human Endogenous Retrovirus Clone 4-1 in Systemic Lupus Erythematosus
Ogasawara, H., Hishikawa, T., Sekigawa, I., Hashimoto, H., Yamamoto, N., & Maruyama, N. (2001) · Autoimmunity · doi:10.3109/08916930108994105 · Cited by 35 · cited 1×
“Our data also suggest that the promotion of clone 4-1 transcription and translation in SLE patients may be related to inactivation of stop codons and DNA hypomethylation of SLE-clone 4-1 (9, 13).”
BackgroundSelf-citationInhibitory effect of interleukin‐16 on interleukin‐2 production by CD4+ T cells
Ogasawara, TAKEDA‐HIROKAWA, SEKIGAWA, HASHIMOTO, KANEKO, & Hirose (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00693.x · Cited by 34 · cited 3×
“IL-16 may play an important role in the induction of such SLE-related CD4 + T-cell abnormalities (18,19).”
BackgroundHIV infection and SLE: their pathogenic relationship.
Sekigawa, I., Kaneko, H., Hishikawa, T., Hashimoto, H., Hirose, S., Kaneko, Y., & Maruyama, N. (1998) · PubMed · Cited by 34
Self-citationT lymphocytes, natural killer cells, cytokines, and immune regulation
Da, H. (1997) · Medical Entomology and Zoology · Cited by 34
KANEKO, H., Hishikawa, T., Sekigawa, I., Hashimoto, H., Okumura, K., & Kaneko, Y. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.4231325.x · Cited by 27
Self-citationA Possible Pathogenic Role of CD8 + T Cells and their Derived Cytokine, IL-16, in SLE
Sekigawa, I., Matsushita, M., Lee, S., Maeda, N., Ogasawara, H., Kaneko, H., Iida, N., & Hashimoto, H. (2001) · Autoimmunity · doi:10.3109/08916930108994108 · Cited by 26 · cited 3×
“Our previous cross-sectional study indicated that serum levels of IL-16 are much higher in SLE patients than in healthy volunteers, and an increase of IL-16 occurs in proportion to disease activity as assessed by the SLE Disease Activity Index (SLEDAI) score (16, 19).”
BackgroundSelf-citationChanges of CD4/CD8 Ratio and Interleukin-16 in Systemic Lupus Erythematosus
Matsushita, M., Hayashi, T., Ando, S., Sekigawa, I., Iida, N., Hashimoto, H., & Hirose, S. (2000) · Clinical Rheumatology · doi:10.1007/pl00011171 · Cited by 21
Self-citationQantitative comparison of human endogenous retrovirus mRNA between SLE and rheumatoid arthritis
Ogasawara, H., Okada, M., Kaneko, H., Hishikawa, T., Sekigawa, I., Iida, N., Maruyama, N., Yamamoto, N., & Hashimoto, H. (2001) · Lupus · doi:10.1191/096120301678416114 · Cited by 19
Self-citationOgasawara, H., Kaneko, H., Hishikawa, T., Sekigawa, I., Takasaki, Y., Hashimoto, H., Hirose, S., Kaneko, Y., & Maruyama, N. (1999) · Rheumatology · doi:10.1093/rheumatology/38.11.1163 · Cited by 18
Self-citationCharacterization of lymphocytes that suppress IL-2 production in systemic lupus erythematosus.
Linker‐Israeli, M., Gray, J. D., Quismorio, F. P., & Horwitz, D. A. (1988) · PubMed · Cited by 13
Linker‐Israeli, M., Fp, Q., & Da, H. (1988) · PubMed · Cited by 13
Research works printed but not linked: 2
- Ogasawara H, Naito T, Kaneko H, Hishikawa T, Sekigawa I, Hashimoto H, Kaneko Y, Yamamoto N, Maruyama N, Yamamoto N: Quantitative analyses of messenger RNA of human endogenous retrovirus in SLE patients. J Rheumatol 28: 533–538, 2001
- Okada M, Ogasawara H, Kaneko H, Hishikawa T, Sekigawa I, Hashimoto H, Maruyama N, Kaneko K, Yamamoto N: Role of DNA methylation in the transcription of human endogenous retrovirus: With reference to the pathogenesis of SLE. J Rheumatol 29: 1678–1682, 2002
Cited by
Endogenous Retroviruses and the Development of Cancer
Kassiotis, G. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302972 · Cited by 195
“Thus, ERV-encoded immunosuppressive domains may contribute to cancer development by establishing the immunosuppression necessary for tumor growth and, in addition to syncytins, the env of HERV-E (54) and HERV-H (55) was shown to possess immunosuppressive potential.”
BackgroundChristensen, T. (2005) · Reviews in Medical Virology · doi:10.1002/rmv.465 · Cited by 151
“Indeed, in a study of PBMCs isolated from patients with SLE, it was shown that a corresponding HERV-E peptide with 53% homology to CKS17 could induce T cell activation, measured as an increase in HLA-DR expression, and promote cytokine production [188] (see Figure 8).”
BackgroundViruses as potential pathogenic agents in systemic lupus erythematosus
Nelson, P., Rylance, P. B., Roden, D., Trela, M., & Tugnet, N. (2014) · Lupus · doi:10.1177/0961203314531637 · Cited by 137
Molecular mechanisms mediated by human endogenous retroviruses (HERVs) in autoimmunity
Balada, E., Ordi‐Ros, J., & Vilardell‐Tarrés, M. (2009) · Reviews in Medical Virology · doi:10.1002/rmv.622 · Cited by 122
Implication of Human Endogenous Retroviruses in the Development of Autoimmune Diseases
Balada, E., Vilardell, M., & Ordi‐Ros, J. (2010) · International Reviews of Immunology · doi:10.3109/08830185.2010.485333 · Cited by 123
“Synthetic peptides derived from this HERV can induce immune abnormalities typical of SLE [46].”
Background
Metadata
- Authors
- Naito, T., Ogasawara, H., Kaneko, H., Hishikawa, T., Sekigawa, I., Hashimoto, H., & Maruyama, N.
- Affiliations
- Juntendo University (JP)
- Tokyo Metropolitan Institute of Gerontology (JP)
- Corresponding author
- Sekigawa, Iwao
- Venue
- Journal of Clinical Immunology
- Published
- 2003-09
- Volume
- 23
- Issue
- 5
- Pages
- 371-376
- ISSN
- 0271-9142 (ISSN-L)
- 1573-2592
- OpenAlex
- W1480278634
- Cited by
- 28
- References
- 32
- Citations by year
- 2026: 1 · 2023: 1 · 2021: 1 · 2018: 1 · 2017: 2 · 2015: 3 · 2014: 6 · 2013: 1
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Journal of Clinical Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- systemic lupus erythematosus, human endogenous retroviruses, p15E, synthetic peptides, T cell activation, T cell anergy, interleukin-6, interleukin-16, autoimmunity, retroviral pathogenesis
- MeSH terms
- Cells, Cultured, HLA-DR Antigens, Humans, Interleukin-2, Lupus Erythematosus, Systemic, Peptides, Retroviridae Proteins, Interleukin-16
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.